Previous 10 | Next 10 |
2023-10-25 09:45:00 ET Summary Cedar Creek Partners is a private investment partnership that focuses primarily on micro and small cap equities. Cedar Creek Partners is managed by Eriksen Capital Management LLC, a registered investment adviser. Major indices were negative in Q3, bu...
Sanofi to use IQVIA’s CRM platform to maximize customer interactions and innovate in the retail channel IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the pharmaceutical and broader life scienc...
2023-10-14 10:45:00 ET Summary We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by...
CEPI will harness IQVIA’s expertise and resources in implementing global clinical research strategies and procedures to rapidly initiate clinical evidence generation around vaccines and other biological countermeasures in response to future health emergencies. Collaboration will al...
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its third-quarter 2023 financial results before the market opens on Wednesday, November 1, 2023. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings rel...
There are more than 3,000 active patient organizations across the U.S., supporting patients through their health journeys and shaping research and care delivery Patient organizations are assuming an ever-expanding role, including developing patient registries to better understand diseases...
IQVIA ™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced a strategic collaboration with argenx to advance treatment to patients with rare autoimmune diseases through innovative ...
IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced it has appointed Richard Staub III, currently senior advisor to the Chairman and CEO, as president of its Research & ...
2023-09-24 23:18:43 ET Summary William Nygren's 13F portfolio value increased from $55.60B to $56.60B this quarter. The portfolio is diversified with around 200 positions, with the largest five stakes being Alphabet, Capital One Financial, Amazon.com, Charter Communications, and F...
2023-09-21 17:32:46 ET Summary Veeva Systems is executing well its migration plan from Salesforce to Veeva Vault CRM, positioning itself for double-digit revenue growth. Better than expected Q2 2023 results with revenue of $590.2 million and GAAP net income increasing 23%. Vee...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 10:00:13 ET Jailendra Singh from Truist Financial issued a price target of $300.00 for IQV on 2024-07-23 09:26:00. The adjusted price target was set to $300.00. At the time of the announcement, IQV was trading at $240.265. The overall price target consensus is...
2024-07-23 10:00:11 ET Elizabeth Anderson from Evercore ISI issued a price target of $270.00 for IQV on 2024-07-23 08:59:00. The adjusted price target was set to $270.00. At the time of the announcement, IQV was trading at $239.5. The overall price target consensus is at...
2024-07-23 07:00:06 ET Luke Sergott from Barclays issued a price target of $275.00 for IQV on 2024-07-23 05:25:00. The adjusted price target was set to $275.00. At the time of the announcement, IQV was trading at $245.23. The overall price target consensus is at $273.93 ...